MedTrace Logo

D-dimer Assay for the Exclusion of Intra-atrial Thrombus Risk Before Ablation of Atrial Fibrillation

NCT02199080 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2506

Last updated 2023-10-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether D-dimer dosage allow to exclude risk of intraatrial thrombus before performing an ablation of atrial fibrillation

Conditions

Interventions

OTHER

D-dimer assay before ablation of atrial fibrillation

Blood sample collection for D-dimers measurement

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Groupe Hospitalier de la Rochelle Ré Aunis

    lead OTHER

Principal Investigators

  • Antoine MILHEM, MD · Groupe Hospitalier de la Rochelle Ré Aunis

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-28
Primary Completion
2016-01-31
Completion
2016-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02199080 on ClinicalTrials.gov